We're sunsetting PodQuest on 2025-07-28. Thank you for your support!

#230 ‒ Cardiovascular disease in women: prevention, risk factors, lipids, and more | Erin Michos, M.D.

2022/11/7

The Peter Attia Drive

AI Chapters

Chapters

Shownotes Transcript

No transcript made for this episode yet, you may request it for free.

#230 ‒ Cardiovascular disease in women: prevention, risk factors, lipids, and more | Erin Michos, M.D.

The Peter Attia Drive

What led Erin to focus on preventive cardiology and women's health?

How do recent trends in cardiovascular disease in women compare to cancer?

Why are early preventative measures crucial for cardiovascular disease risk?

What role does ApoB play in CVD, and why isn't it aggressively treated?

What trends are contributing to the regression in reducing cardiac events?

GLP-1 agonists: How promising are they for treating diabetes and obesity?

What are the female-specific risk factors for ASCVD before and after menopause?

Polycystic ovary syndrome (PCOS): What are its prevalence, etiology, and impacts?

How does having five or more children affect cardiovascular disease risk for women?

What is the impact of oral contraceptives on cardiovascular disease risk?

How does pregnancy affect lipids and other metabolic parameters?

Why are women with familial hypercholesterolemia often undertreated?

Should women stop statins during pregnancy?

How does Erin approach prescribing statins to patients?

What are PCSK9 inhibitors and other non-statin drugs?

What advice does Erin offer for low- and high-risk individuals?

How do nutrition, stress, and lifestyle impact lipids and CVD risk?

What role does Lp(a) play as a risk enhancer for cardiovascular disease?

How does menopause affect cardiovascular disease risk?

How does Erin approach decisions regarding hormone replacement therapy (HRT)?

Why is there an urgent need for more data on women's health?

What is Erin's goal of running a marathon in every state?

Shownotes Transcript

#230 ‒ Cardiovascular disease in women: prevention, risk factors, lipids, and more | Erin Michos, M.D. 02:15:05 Share

The Peter Attia Drive

What led Erin to focus on preventive cardiology and women's health?

How do recent trends in cardiovascular disease in women compare to cancer?

Why are early preventative measures crucial for cardiovascular disease risk?

What role does ApoB play in CVD, and why isn't it aggressively treated?

What trends are contributing to the regression in reducing cardiac events?

GLP-1 agonists: How promising are they for treating diabetes and obesity?

What are the female-specific risk factors for ASCVD before and after menopause?

Polycystic ovary syndrome (PCOS): What are its prevalence, etiology, and impacts?

How does having five or more children affect cardiovascular disease risk for women?

What is the impact of oral contraceptives on cardiovascular disease risk?

How does pregnancy affect lipids and other metabolic parameters?

Why are women with familial hypercholesterolemia often undertreated?

Should women stop statins during pregnancy?

How does Erin approach prescribing statins to patients?

What are PCSK9 inhibitors and other non-statin drugs?

What advice does Erin offer for low- and high-risk individuals?

How do nutrition, stress, and lifestyle impact lipids and CVD risk?

What role does Lp(a) play as a risk enhancer for cardiovascular disease?

How does menopause affect cardiovascular disease risk?

How does Erin approach decisions regarding hormone replacement therapy (HRT)?

Why is there an urgent need for more data on women's health?

What is Erin's goal of running a marathon in every state?

Shownotes Transcript

#230 ‒ Cardiovascular disease in women: prevention, risk factors, lipids, and more | Erin Michos, M.D.